In particular, we highlight the potential of PIEZO2 as a combinatorial target al.ongside existing therapies—including anti-angiogenic regimens, chemo- and radiotherapy—and as a unique molecular interface linking tumor mechanobiology to cancer pain modulation. This evidence concerns the gene PIEZO2 and cancer.